Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Bayer : planning to hold online-only stockholders' meeting on April 28, 2020

03/30/2020 | 05:05am EDT

Leverkusen -- Bayer AG plans to hold its Annual Stockholders' Meeting as an online-only event for the first time in its history as a result of the continuing spread of the coronavirus (SARS-CoV-2). The decision taken by the Board of Management makes use of new legislation. Subject to Supervisory Board approval, the virtual Annual Stockholders' Meeting is set to take place on April 28 from 10 a.m. as originally planned. "We welcome the legislator's decision to open the door to online stockholders' meetings in this exceptional situation," said Werner Baumann, Chairman of the Board of Management, "as providing reliability for our stockholders is very important to us, especially during the crisis."

The health and wellbeing of participants in the stockholders' meeting is a top priority for Bayer. That is why in view of the coronavirus pandemic, the Annual Stockholders' Meeting cannot be held in Bonn on April 28 as a physical event that is attended in person, as had originally been planned. Postponing the Annual Stockholders' Meeting would have left stockholders having to wait months to exercise their right to submit questions and cast votes. "That's why we waited to see how the legislator would respond before deciding how to proceed with this year's Annual Stockholders' Meeting," Baumann explained. "Being able to pay out the proposed dividend of 2.80 euros per share entitled to the dividend on time and in full with stockholder approval is very important to us. In doing so, we aim to provide planning security for stockholders and, as previously announced, enable them to appropriately share in our success in 2019 despite the gravity of the current crisis."

A new version of the Notice of the Annual Stockholders' Meeting will be published by April 6, and thus within the time frame set out by the new legislation. The entire Annual Stockholders' Meeting is set to be broadcast on the company's website. Stockholders will have until April 25 to submit questions on the agenda. As in the past, stockholders will be able to exercise their voting rights by submitting a postal vote ahead of the event or by assigning proxies designated by the company, provided they register for the Annual Stockholders' Meeting before the deadline. Stockholders can make use of either option online, including during the event. Further details will be provided in the notice.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com.

For more information go to www.bayer.com/en/annual-stockholders-meeting-2020

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

.

(C) 2020 M2 COMMUNICATIONS, source M2 PressWIRE

All news about BAYER AG
07:25aBASF  : Swiss voters look set to reject law to help cut carbon emissions
RE
07:08aBASF  : Swiss voters look set to reject law to help cut carbon emissions
RE
06/12BAYER  : Swiss voters to decide on pesticides ban, terrorism law and COVID-19 ai..
RE
06/11EXCLUSIVE : ECB tells Deutsche Bank to find new chairman fast - sources
RE
06/11MARKET CHATTER : Deutsche Bank Facing Increasing Pressure From ECB to Name Chair..
MT
06/10Mexico stalling GMO corn permits ahead of ban, says top farm lobby
RE
06/10Mexico stalling GMO corn permits ahead of ban, says top farm lobby
RE
06/10PRESS RELEASE : Tele Columbus AG: PYUR Business data centre in Leipzig successfu..
DJ
06/10DGAP-PVR : Bayer Aktiengesellschaft: Release -2-
DJ
06/10BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpH..
EQ
More news
Financials
Sales 2021 41 349 M 50 065 M 50 065 M
Net income 2021 3 593 M 4 351 M 4 351 M
Net Debt 2021 38 658 M 46 807 M 46 807 M
P/E ratio 2021 15,7x
Yield 2021 3,79%
Capitalization 52 530 M 63 542 M 63 604 M
EV / Sales 2021 2,21x
EV / Sales 2022 2,08x
Nbr of Employees 99 329
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 64,63 €
Last Close Price 53,47 €
Spread / Highest target 59,0%
Spread / Average Target 20,9%
Spread / Lowest Target -51,4%
EPS Revisions
Managers and Directors
NameTitle
Werner Baumann Chairman-Management Board
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG11.04%63 542
JOHNSON & JOHNSON4.82%434 405
ROCHE HOLDING AG10.68%328 612
PFIZER, INC.9.07%224 747
NOVARTIS AG-0.39%208 035
ABBVIE INC.7.72%203 857